Scientific article
Open access

Dendritic cells direct circadian anti-tumour immune responses

Published inNature, vol. 614, no. 7946, p. 136-143
Publication date2023
First online date2022-12-05

The process of cancer immunosurveillance is a mechanism of tumour suppression that can protect the host from cancer development throughout its lifetime 1,2 . However, it is unknown whether the effectiveness of cancer immunosurveillance fluctuates over a single day. Here we demonstrate that the initial time of day of tumour engraftment dictates the ensuing tumour size across mouse cancer models. Using immunodeficient mice as well as mice lacking lineage-specific circadian functions, we show that dendritic cells (DCs) and CD8 + T cells exert circadian anti-tumour functions that control melanoma volume. Specifically, we find that rhythmic trafficking of DCs to the tumour draining lymph node governs a circadian response of tumour-antigen-specific CD8 + T cells that is dependent on the circadian expression of the co-stimulatory molecule CD80. As a consequence, cancer immunotherapy is more effective when synchronized with DC functions, shows circadian outcomes in mice and suggests similar effects in humans. These data demonstrate that the circadian rhythms of anti-tumour immune components are not only critical for controlling tumour size but can also be of therapeutic relevance.

Citation (ISO format)
WANG, Chen et al. Dendritic cells direct circadian anti-tumour immune responses. In: Nature, 2023, vol. 614, n° 7946, p. 136–143. doi: 10.1038/s41586-022-05605-0
Main files (1)
Article (Published version)
Secondary files (5)
ISSN of the journal0028-0836

Technical informations

Creation08/22/2023 9:24:50 AM
First validation08/22/2023 1:26:42 PM
Update time08/22/2023 1:26:42 PM
Status update08/22/2023 1:26:42 PM
Last indexation10/19/2023 9:25:55 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack